In a murine model of asthma, GA exerted a therapeutic effect on OVA-induced experimental asthma partly by regulating the TH1/TH2 balance through suppressing OX40-OX40 L signalling and p38 MAPK activity24. The gene discussed is TNFRSF4; the disease is asthma.